Main Timeline Video Share
May the Holiday Warm Hearts: Idram and IDBank Support the Children of Heroes Beneficiaries of the "By Your Side" program at IDBank AraratBank Named Large CSR Company of the Year Idram Joins the Fight Against Food Insecurity Ucom’s Renovated Sales and Service Center in Yerevan Mall Reopens 1% idcoin instead of New Year’s suffering: practical tips Idram Junior Donated Books to Schools Big Christmas Market with Idram, IDBank and idplus Ucom Supports Wildlife Monitoring in Ararat Region IDBank, Idram, and idplus at the Big Christmas Market Converse Bank Deputy CEO and CFO, Grant Akopian, Elected to BACEE Board Ucom and SunChild NGO Install a Solar Plant in Alaverdi Kindergarten
Khachaturian Rooftop Grand Opening Supported by IDBankUcom’s Sales and Service Center Reopens at 24/2 Shahumyan Street in Ararat Scholarship recipients of the “Armenian Virtuosos” Program participated in the Järvi Academy and Pärnu Music Festival in Estonia, representing Armenia on the international stageUcom Supports the Installation of a 15 kW Solar Power Plant at the Vayk Sports School New Financial Skills at the Davidbek Games: Idram&IDBankCashIn Services at AraratBank ATMs: Fast, Simple, and SecureUcom Sales and Service Center Reopens at 3/47 Yerevanyan Street in Yeghvard Up to 25% idcoin when purchasing Flyone flight tickets: Idram&IDBank Converse Bank Named Armenia’s Best Digital Bank for Consumers by EuromoneyUcom and Microsoft Innovation Center Help School Students Build Cybersecurity Skills Ucom Supports Installation of 10 kW Solar Plant in Shenavan, Lori Unibank to Raffle a Trip to ItalyCustomer Appreciation Day in Vanadzor: IDBankHaik Kazazyan to Perform Khachaturian’s Violin Concerto at the Closing Concert of the Madeira Classical Orchestra’s 2025/2026 SeasonMy Forest Armenia is a beneficiary of the "Power of One Dram" initiative in July Become a Unibank shareholder and benefit from an attractive investment opportunityIDBank warns of scam calls impersonating pension fundsA little corner of France in Hrazdan, with the partnership of Converse SME Idram is the general partner of the "Towards Conscious Parenting 2026" annual conference Polytechnic University Graduation Ceremony Held with the Support of Unibank
Life

1 in 4 people face side effects after getting COVID-19 vaccine

One in four people experiences side effects after being vaccinated against coronavirus. These are mostly minor side effects like pain at the injection site or headache, Lancet Infectious Diseases reported.

Analysis of data from the ZOE COVID Symptom Study, conducted by researchers at King's College London, found that side effects in the general population after vaccination with Pfizer and AstraZeneca were much lower than those reported in the trials.

The study also reported a significant reduction in infection rates from 12 to 21 days after the first dose of Pfizer (58% reduction) and AstraZeneca (39% reduction) compared to controls. The reduction in infection at least 21 days after the first dose is 69% for Pfizer and 60% for AstraZeneca.

Research has shown that:

  • 25.4% of vaccinated people reported one or more systemic side effects, while 66.2% reported one or more local side effects.
  • 13.5% of participants reported side effects after the first dose of Pfizer, 22.0% after the second dose of Pfizer, and 33.7% after the first dose of AstraZeneca.
  • The most common systemic side effect was a headache. 7.8% of people reported headaches after the first dose of Pfizer and 13.2% after the second dose of Pfizer. 22.8% of people who received the first dose of the AstraZeneca vaccine reported headaches.
  • The second most common systemic side effect was fatigue. 8.4% and 14.4% of participants reported fatigue after the first and second doses of the Pfizer vaccine, and 21.1% reported fatigue after the first dose of the AstraZeneca vaccine.
  • The most common localized side effect was soreness: 57.2% and 50.9% after the first and second doses of Pfizer vaccine and 49.3% after the first dose of AstraZeneca vaccine.

Side effects were more common in people under the age of 55 and in women.